The maintenance of lymphocyte homeostasis by apoptosis is a critical regula
tory mechanism in the normal immune system. The transcription factor NF-kap
pa B has been shown to play a role in protecting cells against death mediat
ed by TNF. We show here that NF-kappa B also has a role in regulating Fas/A
PO-1/CD95-mediated death, a major pathway of peripheral T cell death. Trans
fection of Jurkat cells with the NF-kappa B subunits p50 and p65 confers re
sistance against Fas-mediated apoptosis. Reciprocally, inhibition of NF-kap
pa B activation by a soluble peptide inhibitor or a dominant form of the NF
-kappa B inhibitor, I kappa B, makes the cells more susceptible to Fas-medi
ated apoptosis. Furthermore, inhibition of NF-kappa B activation by a solub
le peptide inhibitor rendered a T cell hybridoma more susceptible to TCR-me
diated apoptosis. Correspondingly, transfection of p50 and p65 provided con
siderable protection from TCR-mediated apoptosis. These observations were c
orroborated by studies on Fas-mediated death in primary T cells. Concanaval
in A-activated cycling T cell blasts from mice that are transgenic for the
dominant I kappa B molecule have increased sensitivity to Fas-mediated apop
tosis, associated with a down-regulation of NF-kappa B complexes in the nuc
leus. In addition, blocking TNF, itself a positive regulator of NF-kappa B,
with neutralizing antibodies renders the cells more susceptible to anti-Fa
s-mediated apoptosis. In summary, our results provide compelling evidence t
hat NF-kappa B protects against Fas-mediated death and is likely to be an i
mportant regulator of T cell homeostasis and tolerance.